loader
Please Wait
Applying Filters...
Close
4

Seqens Seqens

X

Information, Expiry & Status of Health Canada Patents covering Oseltamivir Phosphate.

Client Email Product
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 Gowling Lafleur Henderson LLP (2)

02 Gowling Lafleur Henderson LLP (3)

filter

01 2188835 (5)

filter

01 OSELTAMIVIR PHOSPHATE (2)

02 Oseltamivir Phosphate (3)

filter

01 CAPSULE (1)

02 Capsule (2)

03 POWDER FOR SUSPENSION (1)

04 Powder for Oral Suspension (1)

filter

01 2016-02-26 (5)

Flag Canada
Digital Content Digital Content
URL Supplier Web Content
2188835
45mg
Capsule
Human
2016-02-26
2006-08-08
1996-02-26
TAMIFLU
Oral
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Canada
Digital Content Digital Content
URL Supplier Web Content
2188835
75mg
Capsule
Human
2016-02-26
2006-08-08
1996-02-26
TAMIFLU
Oral
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Canada
Digital Content Digital Content
URL Supplier Web Content
2188835
12mg / mL
Powder for Oral Suspension
Human
2016-02-26
2006-08-08
1996-02-26
TAMIFLU
Oral
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Canada
Digital Content Digital Content
URL Supplier Web Content
2188835
6 mg / mL
POWDER FOR SUSPENSION
Human
2016-02-26
2006-08-08
1996-02-26
TAMIFLU
ORAL
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Canada
Digital Content Digital Content
URL Supplier Web Content
2188835
30 mg
CAPSULE
Human
2016-02-26
2006-08-08
1996-02-26
TAMIFLU
ORAL
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Post Enquiry
POST ENQUIRY